Focus group and survey confirm growing complexity of drug development and increasing adoption of smarter clinical trials Tom Parke, Head of Clinical Technologies, Tessella I was lucky enough to join a focus group at the recent 8th Annual SAS Health Care & Life Sciences Executive Conference (http://www.sas.com/news/preleases/hlsconf-clinicaltrials.html). The group comprising of selected pharmaceutical industry executives, [...]

Researchers identify four cognitive biases that might be slowing drug discovery. By Courtney Andersen In an age of increasing financial and logistical pressures facing biotech and pharmaceutical companies, optimizing R&D success is a critical task. But in a commentary published last year in Drug Discovery Today, Andrew Chadwick of Tessella and Matthew Segall of Optibrium [...]

Today The Telegraph published an article about drug and cosmetic firms planning to cut back on animal testing, click here to see full article.  The time is right for a big push in this area with affordable computing power, sophisticated computer models based on many years’ experience and huge quantities of experimental data now all available. Success [...]

Optibrium, a provider of software solutions for drug discovery, and Tessella, the information technology and consulting services company and world leaders in digital preservation technology, published a new paper highlighting that scientists’ instincts may not always lead them to making good drug discovery decisions. The challenges of decision-making arise from the importance of multiple/conflicting criteria [...]

As pharma R&D leaders bring together their discovery and early development organizations they face tough decisions. How do you optimize project planning across a seamless R&D process? What is the right balance between risk, cost and value in the face of uncertainty? When and how should you deploy predictive technologies such as biomarkers? This webinar [...]

By Deborah Borfitz The first upgrade to a one-of-a-kind simulation tool co-developed by Tessella and Berry Consultants significantly enlarges the proportion of clinical studies that can benefit from simulation of the design…read more

New simulation tool helps drug development team optimise clinical trials Oxford, UK | Texas, US | September 14, 2010. Tessella, the information technology and consulting services company selected by R&D, science and engineering leaders for business-critical assignments and Berry Consultants, leaders in the Bayesian approach to medical statistics announce the availability of their trial design [...]

Tessella are platinum sponsors of  Bio-IT World Conference and Exhibition 2011, taking place at the World Trade Centre in Boston, US on April 12-14, 2011. To find out more or to register online visit http://www.bio-itworldexpo.com/

CAMBRIDGE | OXFORD UK, July 8 2010 – Optibrium, a provider of software solutions for drug discovery, and Tessella, the technology and consulting services company, today published a new paper highlighting that scientists’ instincts may not always lead them to making good drug discovery decisions. The challenges of decision-making arise from the importance of multiple/conflicting [...]

By Andrew T. Chadwick and Matthew D. Segall Better individual and team decision-making should enhance R&D performance. Reproducible biases affecting human decision-making, known as cognitive biases, are well understood by psychologists.  These threaten objectivity and balance and so are credible causes for continuing unpleasant surprises in Development and high operating costs…read more